JAMA Medical News
JAMA Network · American Medical Association
Show overview
JAMA Medical News has been publishing since 2015, and across the 11 years since has built a catalogue of 290 episodes. That works out to roughly 90 hours of audio in total. Releases follow a fortnightly cadence.
Episodes typically run ten to twenty minutes — most land between 14 min and 23 min — though episode length varies meaningfully from one episode to the next. It is catalogued as a EN-language Health & Fitness show.
The show is actively publishing — the most recent episode landed 5 days ago, with 29 episodes already out so far this year. The busiest year was 2025, with 44 episodes published. Published by American Medical Association.
From the publisher
Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.
Latest Episodes
View all 290 episodesPMOS is the New PCOS
New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
Why Exercise Still Matters in the GLP-1 Drug Era
The Search for a Fentanyl Vaccine
New Insights on HFpEF in Patients With Severe Obesity
Ebola Outbreak Update
Is There a Doctor on the Ship?
Bangladesh's New Measles Crisis
New Obesity Definition Stirs Debate
Multi-Cancer Blood Tests Have Arrived
Why GLP-1 Drugs Affect Patients Differently
Treating Methamphetamine Use Disorder With an Antidepressant
Cicada, the SARS-CoV-2 Variant With a Surprising Trajectory
Highlights From the American College of Cardiology's 2026 Scientific Sessions
Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content: PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC
Cancer-Treating Vaccines Are on the Horizon
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "How mRNA Vaccines Could Help Treat Cancer." Related Content: How mRNA Vaccines Could Help Treat Cancer
What Happens When Patients With Decompensated Cirrhosis Stop Drinking?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking." Related Content: New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking
What's New in the Updated Lipid Guidelines?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the New Lipid Guidelines." Related Content: What to Know About the New Lipid Guidelines
The Health Costs of EPA's Heavy Metal Air Pollution Rollbacks
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern." Related Content: Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern
PrEP Prevents HIV—If Patients Can Get It
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "After a Decade of Progress Against HIV, PrEP Enters a Precarious Era." Related Content: After a Decade of Progress Against HIV, PrEP Enters a Precarious Era
AI Tools for Patients Have Arrived
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?" Related Content: Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?